Daniela Bumbaca
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Protein purification and stability 6
- Glycosylation and Glycoproteins Research 5
- Receptor Mechanisms and Signaling 2
- Advanced Biosensing Techniques and Applications 2
-
- Monoclonal and Polyclonal Antibodies Research 12
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- C. Andrew Boswell (13 shared papers)Paul J. Fielder (11 shared papers)Leslie A. Khawli (12 shared papers)Mark S. Dennis (4 shared papers)Yanmei Lu (5 shared papers)Wilman Luk (4 shared papers)Nga Bien‐Ly (3 shared papers)Ryan J. Watts (3 shared papers)
- Journals
- mAbs (5 papers)Molecular Cancer Therapeutics (2 papers)The AAPS Journal (2 papers)Molecular Pharmaceutics (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Daniela Bumbaca
30 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 102
- Radiology, Nuclear Medicine and Imaging 1.1k
- Oncology 743
- Neurology 225
- Immunology 347
- Pharmaceutical Science 95
Countries citing papers authored by Daniela Bumbaca
This map shows the geographic impact of Daniela Bumbaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Bumbaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Bumbaca more than expected).
Fields of papers citing papers by Daniela Bumbaca
This network shows the impact of papers produced by Daniela Bumbaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Bumbaca. The network helps show where Daniela Bumbaca may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Bumbaca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 301 | |
| 2 | 2014 | 259 | |
| 3 | 2015 | 208 | |
| 4 | 2012 | 191 | |
| 5 | 2014 | 166 | |
| 6 | 2011 | 165 | |
| 7 | 2016 | 158 | |
| 8 | 2008 | 102 | |
| 9 | 2012 | 102 | |
| 10 | 2015 | 100 | |
| 11 | 2012 | 97 | |
| 12 | 2011 | 83 | |
| 13 | 2014 | 70 | |
| 14 | 2012 | 52 | |
| 15 | 2014 | 52 | |
| 16 | 2011 | 36 | |
| 17 | 2013 | 36 | |
| 18 | 2011 | 29 | |
| 19 | 2016 | 25 | |
| 20 | 2004 | 24 |
About Daniela Bumbaca
Daniela Bumbaca is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 30 papers that have together received 2.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), HER2/EGFR in Cancer Research (6 papers), Protein purification and stability (6 papers), Glycosylation and Glycoproteins Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Receptor Mechanisms and Signaling (2 papers), Advanced Biosensing Techniques and Applications (2 papers) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Oncology (743 citations), Neurology (225 citations), Immunology (347 citations) and Pharmaceutical Science (95 citations). Daniela Bumbaca has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include C. Andrew Boswell, Paul J. Fielder, Leslie A. Khawli, Mark S. Dennis, Yanmei Lu, Wilman Luk, Nga Bien‐Ly, Ryan J. Watts, Ben‐Quan Shen and Yang Yu. Their work appears in journals such as mAbs, Molecular Cancer Therapeutics, The AAPS Journal, Molecular Pharmaceutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.